113 related articles for article (PubMed ID: 19491955)
1. Effects of some ophthalmic medications on pupil size: a literature review.
Novitskaya ES; Dean SJ; Moore JE; Moore TC; Nagendran S; Sharma A
Can J Ophthalmol; 2009 Apr; 44(2):193-7. PubMed ID: 19491955
[TBL] [Abstract][Full Text] [Related]
2. Ophthalmic preservatives: focus on polyquaternium-1.
Rolando M; Crider JY; Kahook MY
Expert Opin Drug Deliv; 2011 Nov; 8(11):1425-38. PubMed ID: 21905766
[TBL] [Abstract][Full Text] [Related]
3. Neuro-ophthalmologic side-effects of systemic medications.
Pula JH; Kao AM; Kattah JC
Curr Opin Ophthalmol; 2013 Nov; 24(6):540-9. PubMed ID: 24100367
[TBL] [Abstract][Full Text] [Related]
4. Systemic effects of topical ophthalmic medications.
Selvin BL
South Med J; 1983 Mar; 76(3):349-58. PubMed ID: 6131541
[TBL] [Abstract][Full Text] [Related]
5. A diagnostic challenge: dilated pupil.
Caglayan HZ; Colpak IA; Kansu T
Curr Opin Ophthalmol; 2013 Nov; 24(6):550-7. PubMed ID: 24100369
[TBL] [Abstract][Full Text] [Related]
6. Topical ophthalmic drugs and the pediatric patient.
Chung I; Buhr V
Optometry; 2000 Aug; 71(8):511-8. PubMed ID: 15326908
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical nonsteroidal anti-inflammatory drugs and nuclear hardness on maintenance of mydriasis during phacoemulsification surgery.
Liu C; Liu Y; Ye S; Liu L; Zhang W; Wu M
J Ocul Pharmacol Ther; 2014 Dec; 30(10):831-6. PubMed ID: 25230350
[TBL] [Abstract][Full Text] [Related]
8. Effect of brimonidine tartrate 0.10% ophthalmic solution on pupil diameter.
Shemesh G; Moisseiev E; Lazar M; Kesler A
J Cataract Refract Surg; 2011 Mar; 37(3):486-9. PubMed ID: 21333872
[TBL] [Abstract][Full Text] [Related]
9. Ocular and systemic adverse effects of ophthalmic and non ophthalmic medications.
Izazola-Conde C; Zamora-de la Cruz D; Tenorio-Guajardo G
Proc West Pharmacol Soc; 2011; 54():69-72. PubMed ID: 22423585
[TBL] [Abstract][Full Text] [Related]
10. Letter: Caution indicated in handling ophthalmic drugs.
Moore TD; Nold E
Am J Hosp Pharm; 1974 Aug; 31(8):722. PubMed ID: 4852719
[No Abstract] [Full Text] [Related]
11. Brimonidine versus dapiprazole: Influence on pupil size at various illumination levels.
Marx-Gross S; Krummenauer F; Dick HB; Pfeiffer N
J Cataract Refract Surg; 2005 Jul; 31(7):1372-6. PubMed ID: 16105609
[TBL] [Abstract][Full Text] [Related]
12. Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size.
Kesler A; Shemesh G; Rothkoff L; Lazar M
J Cataract Refract Surg; 2004 Aug; 30(8):1707-10. PubMed ID: 15313294
[TBL] [Abstract][Full Text] [Related]
13. Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes.
Thordsen JE; Bower KS; Warren BB; Stutzman R
J Cataract Refract Surg; 2004 Aug; 30(8):1702-6. PubMed ID: 15313293
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule.
Fed Regist; 1998 Feb; 63(35):8888-90. PubMed ID: 10177740
[TBL] [Abstract][Full Text] [Related]
15. Pupil dilation and driving: guidelines for ophthalmic nurses and technicians.
Kirkwood BJ; Kirkwood RA
Insight; 2005; 30(4):22. PubMed ID: 19902698
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new preoperative ophthalmic solution.
Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis.
Lee JH; You YS; Choe CM; Lee ES
J Cataract Refract Surg; 2008 Jun; 34(6):963-7. PubMed ID: 18499002
[TBL] [Abstract][Full Text] [Related]
18. Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.
Regnier A; Lemagne C; Ponchet A; Cazalot G; Concordet D; Gelatt KN
Vet Ophthalmol; 2006; 9(1):39-43. PubMed ID: 16409244
[TBL] [Abstract][Full Text] [Related]
19. Ocular Side Effects of Common Systemic Medications and Systemic Side Effects of Ocular Medications.
Syed MF; Rehmani A; Yang M
Med Clin North Am; 2021 May; 105(3):425-444. PubMed ID: 33926639
[TBL] [Abstract][Full Text] [Related]
20. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
